[Translation] A multi-center, randomized, double-blind, placebo-controlled phase III clinical study to evaluate the safety and efficacy of human interferon α1b inhalation solution in the treatment of respiratory syncytial virus lower respiratory tract infection in children.
主要目的:
评估人干扰素α1b吸入溶液治疗小儿呼吸道合胞病毒性下呼吸道感染(肺炎、毛细支气管炎)的有效性和安全性。
次要目的:
评估在小儿呼吸道合胞病毒性下呼吸道感染患儿中人干扰素α1b吸入溶液血清中药代动力学特征。
[Translation] main purpose:
To evaluate the effectiveness and safety of human interferon α1b inhalation solution in the treatment of respiratory syncytial virus lower respiratory tract infections (pneumonia, bronchiolitis) in children.
Secondary purpose:
To evaluate the serum pharmacokinetic characteristics of human interferon α1b inhalation solution in children with respiratory syncytial virus lower respiratory tract infection.